[AI-driven Vaccine Communicator: the Impact of a Web-based Psychoeducation Programme with a Motivational AI-based Digital Assistant on Covid-19 Vaccine Hesitancy in Hong Kong's Population
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 168
- 试验地点
- 1
- 主要终点
- Vaccine hesitancy at pre-test
研究概览
简要总结
Vaccine hesitancy is defined as 'delay in acceptance or refusal of vaccines, despite the availability of vaccine service' and was named one of the top ten global health threats by the World Health Organization in 2019.
Our proposed study will aim to develop and evaluate the effectiveness of a Web-based psychoeducation programme to address Covid-19 vaccine hesitancy, 'AI-driven Vaccine Communicator' (including educational materials, animations of vaccine research and development, and an MI communication skills-based AI, digital assistant).
Our goal is to standardise our intervention so that it can serve as an effective toolkit for clinicians/healthcare providers to increase Hong Kong residents' motivation to vaccinate and to ensure that the programme can be adapted to viral mutations and newly developed vaccines in the medium/long term.
详细描述
This study is a two-arm, single-blind pilot randomized controlled trial, and it will be adopted to evaluate the efficacy of the 'AI-driven Vaccine Communicator' relative to being self-informed about Covid-19 vaccines.
Also, to address the widespread hesitancy among Hong Kong residents toward Covid-19 vaccines, we will develop a Web-based psychoeducation programme, 'AI-driven Vaccine Communicator,' driven by artificial intelligence (AI) techniques based on the Vaccine Hesitancy Determinants Matrix Model and MI communication skills and concepts (theoretical underpinnings). After developing and piloting this programme, we will test its effectiveness among members of the population who are hesitant about Covid-19 vaccines. The programme will then be refined further and standardised to use the most relevant information and effective communication skills to promote acceptance of Covid-19 vaccines among a wider Hong Kong population. Clinicians and healthcare providers will be able to utilise our programme as a toolkit in their usual practice when working with clients who are hesitant about Covid-19 vaccines.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18 years or above;
- •Hong Kong residents;
- •Show vaccine hesitancy (not taking COVID-19 vaccines or receiving involuntary COVID-19 vaccines);
- •have internet access
- •able to read Chinese or English. Recruitment involved social media promotion and collaborating with community organizations
排除标准
- •People with self-reported cognitive impairments or mental disorders that might interfere with their understanding of the intervention content;
- •People who currently engaged in another clinical trial in relation to Covid-19 vaccines.
结局指标
主要结局
Vaccine hesitancy at pre-test
时间窗: Vaccine hesitancy will be assessed at pre-intervention.
Vaccine hesitancy measured by Adult Vaccine Hesitancy scale and a single question 'plan for next dose'
Vaccine hesitancy at six months follow-up
时间窗: Vaccine hesitancy will be assessed after six months follow-up.
Vaccine hesitancy measured by Adult Vaccine Hesitancy scale and a single question 'plan for next dose'
Vaccine hesitancy at post-intervention
时间窗: Vaccine hesitancy will be assessed five weeks post the commencement of the intervention (at post-intervention).
Vaccine hesitancy measured by Adult Vaccine Hesitancy scale and a single question 'plan for next dose'
Vaccine hesitancy at three months follow-up
时间窗: Vaccine hesitancy will be assessed after three months follow-up.
Vaccine hesitancy measured by Adult Vaccine Hesitancy scale and a single question 'plan for next dose'
次要结局
- Vaccine confidence at pre-test(Vaccine confidence will be assessed at pre-intervention.)
- Vaccine confidence at post-intervention(Vaccine confidence will be assessed five weeks post the commencement of the intervention (at post-intervention).)
- Vaccine confidence at three months follow-up(Vaccine confidence will be assessed after three months follow-up.)
- Vaccine confidence at six months follow-up(Vaccine confidence will be assessed after six months follow-up.)
- Vaccine readiness at pre-test(Vaccine readiness will be assessed at pre-intervention.)
- Vaccine readiness at post-intervention(Vaccine readiness will be assessed five weeks post the commencement of the intervention (at post-intervention).)
- Vaccine readiness at three months follow up(Vaccine readiness will be assessed after three months follow-up.)
- Vaccine readiness at six months follow up(Vaccine readiness will be assessed after six months follow-up.)
- Vaccine-Related Health Literacy at pre-test(Vaccine-Related Health Literacy will be assessed at pre-intervention.)
- Vaccine-Related Health Literacy at post-intervention(Vaccine-Related Health Literacy will be assessed five weeks post the commencement of the intervention (at post-intervention).)
- Vaccine-Related Health Literacy at three months follow up(Vaccine-Related Health Literacy will be assessed after three months follow-up.)
- Vaccine-Related Health Literacy at six months follow up(Vaccine-Related Health Literacy will be assessed after six months follow-up.)
- Trust in government at pre-test(Trust in government will be assessed at pre-intervention.)
- Trust in government at post-test(Trust in government will be assessed five weeks post the commencement of the intervention (at post-intervention).)
- Trust in government at three-months follow up(Trust in government will be assessed after three-months follow up.)
- Trust in government at six-months follow up(Trust in government will be assessed after six-months follow up.)